| HLX10+HLX07 |
Head and Neck Squamous Cell Carcinoma
|
phase II
|
Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
|
| HLX10+HLX07 |
Squamous Non-small-cell Lung Cancer
|
phase II
|
A Randomized, Open-Label, Multicenter, Phase II Study of HLX07 (Anti-EGFR Antibody) In Combination With HLX10 (Anti-PD-1 Antibody) With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line Recurrent or Metastatic Squamous Non-Small Cell Lung Cancer.
|
| HLX10+HLX07 |
Soild Tumours
|
phase II
|
|
| HLX14 |
Healthy Male Volunteers
|
Phase I
|
First subject has been doesd in the international multi-centre phase 3 clinical trial for HLX14 in China for the treatment of postmenopausal osteoporosis in women with high fracture risks.
|
| HLX10 + chemotherapy |
Cervical Cancer
|
phase II
|
A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy
|
